Oncology CRO services and Immuno-Oncology CRO services.

Biotechs looking for Oncology CRO services are partnering with global CRO specialists with a similar fit in terms of culture and flexibility. About half of Novotech’s projects are in Oncology and Immuno-Oncology. Novotech has built teams with deep expertise in Oncology and Immuno-Oncology and strong connections with Oncology key opinion leaders and sites in the various regions.

Novotech has built solid and long-lasting relationships with investigators allowing to quickly identify and recommend the most appropriate sites for your study in Oncology. Site selection is essential to the success of clinical studies in Oncology.

Over the last 25 years, Novotech has partnered with numerous biotechnology companies and completed hundreds of projects in Oncology. Novotech has consistently provided high-quality Oncology CRO services through a  flexible approach that suits the need of small and medium biotechnology companies.


Novotech experience in Oncology and Immuno-Oncology

Novotech has conducted over a hundred trials in Oncology including these Oncology and Immuno-Oncology indications:

Solid tumour clinical trials

  • Bladder Cancer
  • Breast Cancer
  • Cervical Cancer
  • Bladder Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Glioblastoma
  • HCC, Hepatocellular Carcinoma
  • Head & Neck Cancer
  • Melanoma
  • NSCLC, Non-Small Cell Lung Cancer
  • Other
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostatic Cancer
  • Renal Cancer
  • Sarcoma
  • SCLC, Small Cell Lung Cancer
  • Other Solid Tumours

Haematological malignancies clinical trials

  • Chronic Lymphocytic Leukemia (CLL)
  • Acute Myeloid Leukemia (AML)
  • Lymphoma
  • Myeloma
  • Chronic Myelomonocytic Leukemia
  • Non Hodgkin's Lymphoma